Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
Current Editions
To avoid sweeping tariffs, pharmas announce U.S. manufacturing investments, warn of generics shortages
Politics, Policy & Law
Product Development
In BioCentury’s Clinical Report, Pfizer and BMS miss out on market opportunities, and more
Data Byte
Shanghai biotech’s shares double in debut
Politics, Policy & Law
Executive order includes steps to facilitate biosimilar and generic competition, drug importation, PBM transparency
Management Tracks
BioCentury’s Management Roundup also includes updates from Galapagos, Proqr, GC, Gates MRI, Viatris and AB Sciex
BioCentury ISSN 1097-7201